Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B‐type Natriuretic Peptide in the Emergency Department
Open Access
- 1 March 2003
- journal article
- Published by Wiley in Academic Emergency Medicine
- Vol. 10 (3) , 198-204
- https://doi.org/10.1197/aemj.10.3.198
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Opportunities for improvement in the diagnosis and treatment of heart failureClinical Cardiology, 2003
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Pulsatile secretion of atrial natriuretic peptide and brain natriuretic peptide in healthy humansClinical Science, 1999
- Factors determining angiotensin‐converting enzyme inhibitor underutilization in heart failure in a community settingClinical Cardiology, 1998
- Neutral Endopeptidase Inhibition Potentiates the Effects of Natriuretic Peptides in Renin Transgenic Rats.Hypertension Research, 1996
- Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.Journal of Clinical Investigation, 1995
- Mortality from Airways Disorders in Alberta, 1927-1987: An Expanding Epidemic of COPD, but Asthma Shows Little ChangeJournal of Asthma, 1994
- Prevalence and mortality rate of congestive heart failure in the United StatesJournal of the American College of Cardiology, 1992
- Idiopathic dilated cardiomyopathy and atopic disease: Epidemiologic evidence for an association with asthmaAmerican Heart Journal, 1989
- Pathophysiology of congestive heart failureThe American Journal of Cardiology, 1985